WorldWideScience

Sample records for autoradiolysis

  1. Study on autoradiolysis of 5-hydroxymethyl[hydroxy-methyl-3H]uracil

    International Nuclear Information System (INIS)

    Mittag, E.; Noll, S.; Grosse, B.

    1990-01-01

    The autoradiolysis of 5-hydroxymethyl-[hydroxymethyl 3 H]uracil with a specific radioactivity of about 2200 GBq per mmol has been studied. The investigations were carried out in aqueous solutions with radiochemical concentrations between 70 and 1200 MBq/ml using UV-spectroscopy. Tritiated 5-hydroxymethyl-5,6-dihydrouracil in a first order respectively pseudo-first order reaction, was obtained. The determined rate constants were correlated with the radiochemical concentration. (author)

  2. Use of labeled compounds in tracer experiments

    International Nuclear Information System (INIS)

    Anon.

    1991-01-01

    The use of radiotracers in research has become common. This chapter looks at some of the underlying assumptions and advantages of labeled compounds: advantages of radiotracers; availability of suitable tracers and labeled compounds; purity of labeled compounds; autoradiolysis; storage of labeled compounds; detection systems for chromatography and electrophoretic methods. 14 refs., 2 figs

  3. Two newly developed methods for the radioactive labeling of tetanus toxins with substances emitting beta-rays and the usefulness of the compounds thus obtained in radioimmunoassays to determine tetanus antibodies

    International Nuclear Information System (INIS)

    Meyer-Eppler, T.

    1986-01-01

    Described are two methods to label tetanus toxins using either 14C-formaldehyde or succinimidyl-3H- propionate as radioactive tracers. The question as to whether the labeled compounds thus obtained can be introduced into RIAs for the detection of tetanus antibodies is also discussed. The immunoreactivity of 3H-toxin is not perceptibly changed by the labeling procedure. The compound can be compared to 125I-labeled toxin, although it suffers no adverse effects from long-term due to autoradiolysis. (TRV) [de

  4. The analysis of radiolysis impurities in 18F-FDG and methods of repurification

    International Nuclear Information System (INIS)

    Jinming Zhang; Yungang Li; Jian Liu; Xiaojun Zhang; Jiahe Tian

    2010-01-01

    To investigate the radio impurity in the radiolysis of 18 F-FDG at high radiodose and radioconcentrated solutions and develop methods of repurification. The radiolysis of 18 F-FDG was analyzed by TLC. The radio-impurity was confirmed by biodistribution and small animal PET/CT studies. 18 F-FDG was unstable at high radioconcentration over 37 GBq/mL or under basic condition. TLC, biodistribution and PET/CT all indicated that the main autoradiolysis byproduct was free fluoride ion. The radiolyzed 18 F-FDG was repurified by solid-phase extraction (SPE) column. The repurified 18 F-FDG had a radiochemical purity (RCP) of over 99% and significantly lower bone uptake than that was before repurification (P = 0.0003). There was a positive correlation between the recovery yield and the purity of 18 F-FDG (R 2 = 0.66). (author)

  5. Preparation of 19-iodocholestrol labelled with I-125 and its study as a 'tracer' of plasma lipoprotein

    International Nuclear Information System (INIS)

    Rodriquez Barquero, L.

    1988-01-01

    A technique of synthesis of the 19-iodocholesterol labelled with I-125, modified in some steps from other methods published previously, is described. We have obtained a product with high chemical (96%) and radiochemical (99,9%) purities. The yield was higher and the time necessary to prepare it was lower than other methods reported. The study of thermal and radiolytic stability showed that the 19-iodocholesterol-I-125 was not broken by autoradiolysis whereas the I-125 was separated from the molecule when the temperature was increased. The use of this 19-iodocholesterol-I-125 as a tracer of cholesterol of plasma lipoprotein showed some properties of LCAT and CETP and also showed the different capacity of VLDL and LDL to transport cholesteryl esters. (author) 105 refs

  6. Radiation and chemical stability of 2-deoxy-2-[18F]fluoro-D-glucose radiopharmaceutical

    International Nuclear Information System (INIS)

    Buriova, M.

    2004-07-01

    Qualitative and quantitative analytical technique of low-molecular components of chemical and radiation-chemical decomposition of 2-deoxy-2-[ 18 F]fluoro-D-glucose, 2-[ 18 F]FDG radiopharmaceutical was developed for its extended QC by HPLC with mass-spectrometric electro-spray ionisation detector (ESI MS). The analysis constituted from the LC on silica gel NH 2 bonded column combined with MS, UV-VIS, refraction index and radiometric detectors, and TLC on silica gel and high-performance TLC (HPTLC) on silica gel NH 2 bonded as at the LC column. Condition of analysis, the composition of mobile phase at HPLC and the regime of ESI MS were optimised on the maximal intensity of the signals of analytes, which were predicted for commercial 2-[ 18 F]FDG and its decomposition products. A modern LC/MS system was demonstrated to be suitable not only for identification of unknown analytes, but also for complex analysis of solutes except [ 18 F]F - . This was advantageous for the 2-[ 18 F]FDG autoradiolysis assessment about which no data were published. For comparative purposes, were used a classic TLC on silica gel with mobile phase acetonitrile: water at 95:5 v/v, and HPTLC on NH 2 modified silica gel like the LC column. Mobile phase was identical as by LC/MS method (acetonitrile: 4 mM aqueous solution of ammonium formate 80:20 v/v). Retention times of reference samples: fluorodeoxyglucose, glucose, mannose, arabinose, deoxyglucose, gluconic and glucuronic acids at HPLC were established. Equal composition of the inlet sample and mobile phase was found important to avoid increased background of the MS detector and asymmetry of the chromatographic peaks. Reference substance detectability was investigated for various detectors. Characteristic ions were established for the analytes under consideration. Optimal performance of the ESI MS detector was discovered in negative ions mode or single ion monitoring (SIM) regime. The most intensive signal was observed for all analyte

  7. The study of labeling with iodine-131 of monoclonal antibody anti-CD20 used for the treatment of non-Hodgkin lymphoma

    International Nuclear Information System (INIS)

    Akanji, Akinkunmi Ganiyu

    2006-01-01

    Lymphomas are malignancies of the lymphatic system, described by Thomas Hodgkin in 1932. Traditionally, lymphomas are classified in two basic groups: Hodgkin disease and non-Hodgkin lymphoma (NHL). Patients with NHL were earlier treated with radiotherapy alone or in combination with immunotherapy using monoclonal antibody anti-CD20 (ex., Rituximab-Mabthera, Roche). However, Radioimmunotherapy is a new modality of treatment for patients with NHL, in which cytotoxic radiation from therapeutic radioisotopes is delivered to tumors through monoclonal antibodies. This study focused on labeling conditions of monoclonal anti-CD20 (ex., Rituximab-Mabthera, Roche) with iodine-131, by direct radioiodination method using Chloramine-T as oxidizing agent. Labeling parameters investigated were: Radiochemical purity (RP), method of purification, incubation time, antibody mass, oxidative agent mass, stability in vitro, immunoreactivity and biological distribution performed in normal Swiss mouse. Product of high radiochemical purity was obtained with no notable difference between the methods applied. No clear evidence of direct influence of incubation time on radiochemical purity of the labeled antibody was observed. Whereas, a clear evidence of direct influence of activity on radiochemical purity of the labeled antibody was varied. After purification the labeled product presented radiochemical purity of approximately 100 %. Product of superior radiochemical yield was observed when standard condition of labeling was used. The labeled product presented variation in radiochemical purity using five different stabilizer conditions. The condition in which gentisic acid combined with freeze appears more suitable and capable of minimizing autoradiolysis of the antibody labeled with freeze appears more suitable and capable of minimizing autoradiolysis of the antibody labeled with high therapeutic activity of iodine-131. The labeled product presented low immunoreactivity when compared to the

  8. Mathematical simulation of gas pressure in fibre-reinforced concrete container at radiation and biological decomposition of cellulose, bituminized and concrete radwastes

    International Nuclear Information System (INIS)

    Kuruc, J.; Kvito, P.

    2005-01-01

    Fibre-reinforced concrete container (FRCC) are used for long-time repository of radioactive wastes. Low- and middle-active radwastes from operation of the NPPs V-1, V-2 Jaslovske Bohunice, Mochovce NPP and from decommissioned NPP A-1 (Jaslovske Bohunice) are treated in the plant SE-VYZ in Jaslovske Bohunice and after immobilisation are deposited in National Radwaste Repository Mochovce (RU RAO). After filling of the RU RAO, FRCC will be stored during 300 years. During this time the integrity of the FRCC must be guaranteed. By the influence of autoradiolysis of the cellulose and bituminized radwastes as well as in cement grout the gases are formed, mainly the hydrogen, methane and carbon dioxide. In the case of presence of available water (a w ≥ 0.63) and in presence of microbes and moulds at appropriate conditions the biological decomposition of cellulose materials may proceed with formation of H 2 , CH 4 a CO 2 . With increasing of developed gases may increase pressure in FRCC, that may initiate the loss of integrity of the FRCC with following endangering of radiation safety of the RU RAO, respectively of the territory over the repository.Authors developed the new mathematical model of pressure of gases in FRCC and in deposited barrels with cellulose and bituminized radwastes. The mathematical model is based on biological decomposition of cellulose materials as well as on radiation decomposition of cellulose, bitumen and concrete. In this mathematical model the diffusion through the walls of FRCC is the main process responsible for decreasing of the pressure. This model was developed in two basic variants: (1) Mathematical model of gas pressure in FRCC as function of dose; (2) Mathematical model of gas pressure in FRCC as function of mass of cellulose

  9. The study of labeling with Iodine-131 of monoclonal antibody anti-CD20 used for the treatment of non-Hodgkin lymphoma

    International Nuclear Information System (INIS)

    Akanji, Akinkunmi Ganiyu

    2006-01-01

    Lymphomas are malignancies of the lymphatic system, described by Thomas Hodgkin in 1932. Traditionally, lymphomas are classified in two basic groups: Hodgkin disease and non-Hodgkin lymphoma (NHL). Patients with NHL were earlier treated with radiotherapy alone or in combination with immunotherapy using monoclonal antibody anti-CD20 (ex., Rituximab-Mabthera, Roche). However, Radioimmunotherapy is a new modality of treatment for patients with NHL, in which cytotoxic radiation from therapeutic radioisotopes is delivered to tumors through monoclonal antibodies. This study focused on labeling conditions of monoclonal antibody anti-CD20 (Rituximab-Mabthera, Roche) with iodine-131, by direct radioiodination method using Chloramine-T as oxidizing agent. Labeling parameters investigated were: Radiochemical purity (RP), method of purification, incubation time, antibody mass, oxidative agent mass, stability in vitro, stability in vivo, immunoreactivity and biological distribution performed in normal Swiss mouse. Product of high radiochemical purity was obtained with no notable difference between the methods applied. No clear evidence of direct influence of incubation time on radiochemical purity of the labeled antibody was observed. Whereas, a clear evidence of direct influence of activity on radiochemical purity of the labeled antibody was observed when antibody mass was varied. After purification, the labeled product presented radiochemical purity of approximately 100 %. Product of superior radiochemical yield was observed when standard condition of labeling was used. The labeled product presented variation in radiochemical purity using five different stabilizer conditions. The condition in which gentisic acid was combined with freeze appears more suitable and capable of minimizing autoradiolysis of the antibody labeled with high therapeutic activity of iodine-131. The labeled product presented low immunoreactivity when compared to the literature. Biological distribution in

  10. The study of labeling with Iodine-131 of monoclonal antibody anti-CD20 used for the treatment of non-Hodgkin lymphoma; Estudo de marcacao com Iodo-131 de anticorpo monoclonal anti-CD20 na terapia de linfoma nao-Hodgkin

    Energy Technology Data Exchange (ETDEWEB)

    Akanji, Akinkunmi Ganiyu

    2006-07-01

    Lymphomas are malignancies of the lymphatic system, described by Thomas Hodgkin in 1932. Traditionally, lymphomas are classified in two basic groups: Hodgkin disease and non-Hodgkin lymphoma (NHL). Patients with NHL were earlier treated with radiotherapy alone or in combination with immunotherapy using monoclonal antibody anti-CD20 (ex., Rituximab-Mabthera, Roche). However, Radioimmunotherapy is a new modality of treatment for patients with NHL, in which cytotoxic radiation from therapeutic radioisotopes is delivered to tumors through monoclonal antibodies. This study focused on labeling conditions of monoclonal antibody anti-CD20 (Rituximab-Mabthera, Roche) with iodine-131, by direct radioiodination method using Chloramine-T as oxidizing agent. Labeling parameters investigated were: Radiochemical purity (RP), method of purification, incubation time, antibody mass, oxidative agent mass, stability in vitro, stability in vivo, immunoreactivity and biological distribution performed in normal Swiss mouse. Product of high radiochemical purity was obtained with no notable difference between the methods applied. No clear evidence of direct influence of incubation time on radiochemical purity of the labeled antibody was observed. Whereas, a clear evidence of direct influence of activity on radiochemical purity of the labeled antibody was observed when antibody mass was varied. After purification, the labeled product presented radiochemical purity of approximately 100 %. Product of superior radiochemical yield was observed when standard condition of labeling was used. The labeled product presented variation in radiochemical purity using five different stabilizer conditions. The condition in which gentisic acid was combined with freeze appears more suitable and capable of minimizing autoradiolysis of the antibody labeled with high therapeutic activity of iodine-131. The labeled product presented low immunoreactivity when compared to the literature. Biological distribution in

  11. The preparation and its believable effect of pentavalent ruenium-188 dimercaptosuccinic acid in a patient with medullary thyroid carcinoma

    International Nuclear Information System (INIS)

    Cheng Jingyi; Zhang Yingjing; Wan Danjing; Shao Peng; Wang Xincun; Jiang Changying

    2004-01-01

    Background: Dimercaptosuccinic acid (DMSA) forms a complex with pentavalent rhenium-188, known as 188 Re(V)-DMSA. This radiopharmaceutical has been shown to localize in a number of tumour types, most notably medullary thyroid carcinoma (MTC) and in bone metastases and other bone lesions. We have previously shown that 186 Re(V)-DMSA could be strongly uptaked by the lesion of MTC similar to that observed in the images of 99m Tc(V)-DMSA and had potential therapeutic value in these patients. Compared with 186Re, the 188Re has the advantages of its ready availability from a generator. Thus the aim of this study was to establish a method of reliable preparation of 188 Re(V)-DMSA and to evaluate its potential as a targeted radiotherapy agent to patient with MTC. Material and Method: The complex was prepared by reducing 188 Re in the presence of DMSA with stannous chloride at the condition of pH 1.5. The reaction was taken to completion by heating the complex in a boiling water bath for 30 minutes. Excess stannous chloride was required and the presence of hydrochloric acid didn't reduce the yield of labelling. A large dose of ascorbic acid was used to minimize autoradiolysis. The products were analysed with high-performance liquid chromatograms (HPLC) and thin layer chromatography (TLC) using a mobile phase consisting of n-butanol: acetic: water = 3:2:3 by volume. The TLC chromatograms were also visualized and quantified by gamma camera imaging. With the agreement, a patient who had a liver metastatic lesion from MTC but no symptoms (patient I) and another who had bone metastatic MTC and severe symptoms (patient II) were recruited . Both volunteers confirmed by a prior 99m Tc(V)-DMSA scan received a dose of 74 MBq of 188 Re(V)-DMSA and imaged at 3 hours with a GE Millennium VG ECT/CT. Results: The preparation had a good results with a labeling rate more than 95% and a stability in vitro more than 24 hours. The complex was a clear yellow solution which can be adjusted to p